Metronidazole

is prescribed to treat:

• Bacterial and parasitic infections, especially anaerobic bacteria • Various related conditions in the antibiotics category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Metronidazole (Flagyl) is a nitroimidazole antimicrobial active against anaerobic bacteria and several protozoa. It is used for bacterial vaginosis, trichomoniasis, giardiasis, amoebiasis, C. difficile colitis, intra-abdominal and pelvic infections, diverticulitis, and dental infections. Its spectrum is unusual — it covers organisms that most other oral agents miss entirely.

Mechanism of Action

Metronidazole is a prodrug that requires reduction of its nitro group to become active, and that reduction happens only in a low-oxygen environment. Anaerobic bacteria and anaerobic protozoa possess the electron transport proteins with sufficiently negative redox potential to perform it; aerobic organisms and human cells do not.

Once reduced, the resulting reactive intermediates damage microbial DNA, causing strand breakage and cell death. The oxygen-dependence of activation is the entire basis of its selectivity, and it is why metronidazole has essentially no activity against aerobic bacteria — a genuine limitation that means it is frequently combined with another agent for mixed infections.

This is also why metronidazole works well in abscesses and deep tissue infections, where oxygen tension is low, and why it is a standard component of regimens for intra-abdominal infection where anaerobes and aerobic Gram-negatives coexist.

Resistance remains comparatively uncommon, though it is rising in Helicobacter pylori and in some Bacteroides species.

The Alcohol Question

Patients are routinely told to avoid alcohol during and for several days after a course, on the basis of a disulfiram-like reaction — flushing, nausea, vomiting, headache, and palpitations from acetaldehyde accumulation.

The evidence for this is considerably weaker than the strength of the warning suggests. Controlled studies have not consistently reproduced the reaction, and the mechanism proposed for it is questionable. Several reviews have concluded the interaction is likely overstated or absent.

The practical position most clinicians take is to continue advising avoidance, since the advice is low-cost, individual case reports exist, and alcohol is not helpful during an infection in any case — but without presenting it as a certainty, and without alarming a patient who has already had a drink. Telling someone they are in danger when the evidence does not support it damages credibility for the warnings that do matter.

Clinical Use

Metronidazole is first-line for bacterial vaginosis and trichomoniasis — in the latter, partner treatment is essential, since untreated partners reinfect and this is the most common reason for apparent treatment failure. The bacterial vaginosis article covers distinguishing it from candidal infection, which over-the-counter antifungals will not treat and which is a frequent source of delayed care.

For C. difficile infection, metronidazole has been displaced. Oral vancomycin and fidaxomicin are now preferred, having demonstrated superior cure rates, and metronidazole is reserved for situations where those are unavailable. A clinician reaching for metronidazole first in C. difficile is following superseded guidance.

It is used in combination for intra-abdominal and pelvic infections, in H. pylori eradication regimens, and topically for rosacea, where it is effective and avoids systemic exposure. Our gastrointestinal team manages the abdominal indications, and the CDC antibiotic prescribing resource covers stewardship.

Monitoring and Follow-Up

Short courses require no laboratory monitoring. Prolonged therapy warrants periodic blood counts.

Peripheral neuropathy is the adverse effect that matters most with extended use. It is dose- and duration-related, presents as numbness and tingling in the extremities, and may not fully reverse if treatment continues after symptoms begin. Patients on courses longer than a few weeks should be asked about it directly, and new sensory symptoms should prompt stopping rather than watchful waiting.

Central nervous system effects — dizziness, confusion, ataxia, and rarely encephalopathy or seizures — occur mainly with prolonged or high-dose therapy.

A metallic taste is very common, harmless, and worth mentioning in advance, since patients otherwise interpret it as something being wrong. Dark or reddish-brown urine is also harmless and expected. Nausea is common; taking doses with food helps.

Metronidazole potentiates warfarin significantly and INR requires closer monitoring. It also raises lithium levels. The MedlinePlus metronidazole entry covers the interaction profile.

Special Populations

In pregnancy, metronidazole is used for symptomatic bacterial vaginosis and trichomoniasis. Earlier concerns about first-trimester use have not been supported by accumulated data, and untreated trichomoniasis carries its own pregnancy risks. It is used in breastfeeding, though some clinicians advise timing doses to minimise infant exposure with single high doses.

In hepatic impairment, clearance is reduced and dose adjustment is warranted, since metronidazole is metabolised by the liver; kidney impairment requires less adjustment. In older adults, neurotoxicity is more likely and courses should be kept as short as the indication allows.

Prolonged or repeated courses warrant particular care given the cumulative neuropathy risk, and a patient on long-term suppressive metronidazole should have that decision periodically revisited.

Topical and vaginal preparations deliver far lower systemic exposure than oral therapy and carry correspondingly fewer concerns. Vaginal metronidazole gel treats bacterial vaginosis effectively with minimal absorption, which suits patients who tolerate the oral form poorly, and the topical gel for rosacea can be used for months without the neuropathy risk that governs prolonged oral use. The alcohol advice, whatever its merits for oral therapy, is not a realistic concern with topical application. The CDC treatment guidelines for bacterial vaginosis set out the regimen options.

When to Contact Your Doctor

Report numbness, tingling, or burning in the hands or feet promptly — this is peripheral neuropathy, and stopping early improves the chance of full recovery. Report dizziness, confusion, unsteadiness, or difficulty with coordination.

Seek urgent care for seizure. Report severe or persistent watery diarrhoea with abdominal cramping, which may indicate C. difficile — including after treatment for something else. Any blistering or peeling rash needs immediate evaluation.

A metallic taste and darkened urine are expected and harmless. If you are being treated for trichomoniasis, ensure your partner is treated too, or reinfection is likely.

To discuss an infection that is not responding, address side effects, or review long-term metronidazole use, contact us or schedule a visit.